1-5 of 5
Ken M. Kosak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Drug-Free Macromolecular Therapeutics Induce Apoptosis in Cells Isolated from Patients with B Cell Malignancies with Enhanced Apoptosis Induction By Pretreatment with Gemcitabine

Jiawei Wang, Lian Li, PhD, Jiyuan Yang, PhD, Phillip M. Clair, MS, Martha Glenn, MD, Deborah M. Stephens, D. Christopher Radford, PhDCandidate, Ken M. Kosak, Michael W. Deininger, MD PhD, Paul J Shami, MD, Jindřich Kopeček, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4426.
https://doi.org/10.1182/blood-2018-99-112001
Published: 2018
Journal Articles

The Nitric Oxide-Generating Prodrug Js-K Is Selectively Toxic Towards AML Compared to Normal Human Hematopoietic Cells

Kristi J. Smock, MD, William L. Heaton, MS, Anthony D. Pomicter, MS, Ronda A Crist, MT, Ken M Kosak, BS, Kenneth M Boucher, PhD, George M. Rodgers, MD PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD, Paul J Shami, MD
Journal: Blood
Blood (2016) 128 (22): 5217.
https://doi.org/10.1182/blood.V128.22.5217.5217
Published: 2016
Journal Articles

CX-01, a Low Anticoagulant Heparin, May Enhance Count Recovery and Treatment Efficacy in Acute Myeloid Leukemia

Tibor J. Kovacsovics, MD, Alice S. Mims, MD MSCR, Mohamed E Salama, MD, Jeremy M Pantin, MD, Ken M Kosak, B.S., Narayanam Rao, PhD, Peter Ahorukomeye, Martha Glenn, MD, Michael W. Deininger, MD PhD, Kenneth M Boucher, PhD, Linda M Bavisotto, MD, Gerardo Gutierrez-Sanchez, PhD, Thomas P Kennedy, MD MPH, Stephen Garrett Marcus, MD, Paul J Shami, MD
Journal: Blood
Blood (2016) 128 (22): 5220.
https://doi.org/10.1182/blood.V128.22.5220.5220
Published: 2016
Journal Articles

The Nitric Oxide-Generating Prodrug Js-K Reverses the Multi-Drug Resistance Phenotype in AML Cells

Stephan Morys, BS, Catherine Gannage, Moises Terrazas, MS, Imit Kaur, PhD, Ken M Kosak, BS, Paul J Shami, MD
Journal: Blood
Blood (2016) 128 (22): 5127.
https://doi.org/10.1182/blood.V128.22.5127.5127
Published: 2016
Journal Articles

Synergy Studies between the Nitric Oxide (NO) Donor JS-K and Other Anti-Leukemic Agents.

Paul J. Shami, MD, Jordan K. Eddington, Vidya Udupi, PhD, Ken M. Kosak, MS, Joseph E. Saavedra, PhD, Larry K. Keefer, PhD
Journal: Blood
Blood (2006) 108 (11): 4396.
https://doi.org/10.1182/blood.V108.11.4396.4396
Published: 2006